RBBP9 and neoplasm: We also observed a significant increase in the number of small tumors (≤3 mm in diameter) in Rbbp9-/- mice, whereas the number of large tumors (>3 mm) was not significantly altered (Figure 3B), suggesting that the loss of RBBP9 enhances the initiation of inflammation-induced tumorigenesis rather than tumor growth.